Psilocybin is Being Studied to Help Treat Autism Spectrum Disorder
Psilocybin could potentially revolutionize the treatment of autism spectrum disorder (ASD). At the moment, the therapeutics market for ASD is valued at approx. $3.2 billion, and could reach about $4.6 billion by 2026, given the rising global incidence. In addition, about 1 in 54 children has been identified as having ASD, according to the Centers for Disease Control and Prevention. Unfortunately, there’s a rather large unmet medical need when it comes to ASD. However, that could potential change with the use of psychedelics, like psilocybin, which is currently being studied by
Nova Mentis Life Science Corp. (CSE:NOVA)(OTCPK:LIBFF). Other top psychedelic companies looking into the positive effects of such drugsinclude
The global CBD-infused beverage market is expected to jump from about $89 million to more $1.4 billion just over the next three years, according to Zenith Global. By 2024, that number could soar to about $4.4 billion. In addition, according to Grand .
BevCanna Completes $5M Capital Injection, Including a Fully-Subscribed $3 5M Above Market Offering at $1 50 financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Some of the Top Pharmaceutical Companies to Watch in New Year 2021
“Glioblastoma is the most common and aggressive cancerous brain tumour in adults due to its resistance to therapy. Treatment usually involves surgery, followed by chemotherapy and radiation therapy. Despite these intensive efforts, in most cases tumour cells regrow after treatment and the cancer recurs,” reports Science Daily. However, there may be a treatment option with the development of Berubicin, an anthracycline anticancer drug used for the treatment of malignant gliomas, as noted by Targeted Oncology.
As reported by Grand Review Research, “According to U.S. National Cancer Institute GBM is considered as the most aggressive form of brain cancer which represents 15.4% of all primary brain tumors and about 60% - 75% of all astrocytoma and shows rapid growth rate of benign cells in the organ. Currently unavailable therapies and prognosis for the treatment of GBM is expected to impact the marke
With Bitcoin at Record Highs, These are Some of the Top Companies Thriving
The cryptocurrency bull market appears alive and well, with Bitcoin soaring above $28,500. All thanks to increased interest from institutional and retail investors, and concerns about potential inflationary impact of the latest stimulus package. In fact, according to Reuters, the cryptocurrency is being “buoyed by demand from larger investors attracted to its potential for quick gains, purported resistance to inflation and expectations it will become a mainstream payment method.” In addition, “While this is a major milestone for this nascent asset class, as retail, institutional, and blue-chip investors alike allocate more capital to this space, it would not be surprising to see other coins follow in BTC’s footsteps and for this upward trajectory to be sustained into 2021.” Better, analysts are bullish on Bitcoin, as well. Citibank for example says we could see $318,000 BTC in 2021.